Just another WordPress site

Interralationships Among CUD Prevalence, and Prevalence of Cannabis-related Hospitalizations, and Total Illicit Cannabis Consumption

Sep 27, 2022


Illicit Market, CUD, and Cannabis-Related Hospitalizations

Few scientific studies examine the prevalence of hospitalization cases in cannabis users, even though it is a common reason given against cannabis legalization. Evidence suggests that hospitalization rates could potentially predict later diagnosis of Cannabis Use Disorder (CUD). CPPC’s preliminary analysis at the state level provides a snapshot of state-wide hospitalizations in cannabis users for 19 states – Arizona, California, Connecticut, Florida, Georgia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Hampshire, New Jersey, New Mexico, New York, Ohio, Pennsylvania, Virginia and Washington.

We found that on average across these 20 states, approximately 6% of those who used cannabis in the past year reported going to the hospital for a cannabis-specific issue at least once in the past year, and an additional 5% reported doing so in the past, but more than a year ago.

On page 2, we see consistent, moderate-size correlations within states between problematic cannabis use, cannabis-related hospitalizations, and illicit cannabis consumption derived from a dealer. These findings provide initial evidence that types of illicit cannabis consumption may be associated with elevated risk of problematic cannabis use and cannabis- related hospitalizations, which provides a potential bridge point between public health officials, state regulators, and the cannabis industry given the association between legal cannabis implementation and lowering of illicit cannabis consumption.

View the report here.



Other Posts

Recommended Approaches to Evaluate Methodologies and Technologies for the Detection of Cannabis-Impaired Driving

In September 2023, New York State Department of Health (DOH) issued a Request for Information (RFI) regarding methodologies and technologies used for the detection and assessment of driving under-the-influence of cannabis (DUIC). The RFI purpose is to assist the DOH in assessing the current state of research on impairment due to cannabis ingestion, and to review current devices that can be used to detect impairment. Moreover, the DOH is seeking to identify research institutions in higher education that are currently performing this type of research.

read more

Maryland Medical Cannabis Patient Survey Report 2022

The Maryland Medical Cannabis Commission sponsored this survey and report from Cannabis Public Policy Consulting (CPPC) to examine patterns of use, perceptions of risk and benefit, and occurrence of high-risk
behaviors related to cannabis use in the medical cannabis patient population. More than 13,000 medical cannabis patients took part in the survey, which was conducted in September 2022, prior to the General Election referendum to legalize adult use in the state. A second, post referendum survey is planned for fall 2023.

read more